Advanced Catheter Therapies

About:

Advanced Catheter Therapies develops catheter technologies targeting vascular disease including thrombosis, inflammation, and occlusions.

Website: http://acatheter.com

Top Investors: Launch Tennessee, Innova Memphis, Toray Industries, Blank Slate Ventures, Chattanooga Renaissance Fund

Description:

Advanced Catheter Therapies, an early stage research and development medical device company, has a portfolio of innovative catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. ACT is developing a revolutionary device for restenosis (re-blockage of blood vessels) and as well as catheters for endovascular debulking (clearing of blocked blood vessels).

Total Funding Amount:

$14.2M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Chattanooga, Tennessee, United States

Founded Date:

2008-04-18

Contact Email:

paul(AT)acatheter.com

Founders:

Dirk Hoyns, Paul J. Fitzpatrick, Rex Teeslink

Number of Employees:

1-10

Last Funding Date:

2019-03-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai